Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

Research article (Gut, 2019) · cited 35× · AI/ML
Press Enter · cited answer in seconds

Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

Summary

Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial is a scholarly article[1].

Key Facts

  • Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial's instance of is recorded as scholarly article[2].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial. Retrieved May 24, 2026, from https://4ort.xyz/entity/tight-control-for-crohns-disease-with-adalimumab-based-treatment-is-cost-effective-an-economic-assessment-of-the-calm-tr
MLA “Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/tight-control-for-crohns-disease-with-adalimumab-based-treatment-is-cost-effective-an-economic-assessment-of-the-calm-tr.
BibTeX @misc{4ortxyz_tight-control-for-crohns-disease-with-adalimumab-based-treatment-is-cost-effective-an-economic-assessment-of-the-calm-tr_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial}}, year = {2026}, url = {https://4ort.xyz/entity/tight-control-for-crohns-disease-with-adalimumab-based-treatment-is-cost-effective-an-economic-assessment-of-the-calm-tr}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial — https://4ort.xyz/entity/tight-control-for-crohns-disease-with-adalimumab-based-treatment-is-cost-effective-an-economic-assessment-of-the-calm-tr (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/tight-control-for-crohns-disease-with-adalimumab-based-treatment-is-cost-effective-an-economic-assessment-of-the-calm-tr · Last refreshed: